These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167 [TBL] [Abstract][Full Text] [Related]
3. Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device. Gregoric ID; Bruckner BA; Jacob L; Kar B; Cohn WE; La Francesca S; Frazier OH Ann Thorac Surg; 2008 May; 85(5):1646-9. PubMed ID: 18442556 [TBL] [Abstract][Full Text] [Related]
4. Improved durability of the HeartMate XVE left ventricular assist device provides safe mechanical support up to 1 year but is associated with high risk of device failure in the second year. Martin J; Friesewinkel O; Benk C; Sorg S; Schultz S; Beyersdorf F J Heart Lung Transplant; 2006 Apr; 25(4):384-90. PubMed ID: 16563965 [TBL] [Abstract][Full Text] [Related]
5. Device exchange after primary left ventricular assist device implantation: indications and outcomes. Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192 [TBL] [Abstract][Full Text] [Related]
6. HeartMate VE LVAS design enhancements and its impact on device reliability. Dowling RD; Park SJ; Pagani FD; Tector AJ; Naka Y; Icenogle TB; Poirier VL; Frazier OH Eur J Cardiothorac Surg; 2004 Jun; 25(6):958-63. PubMed ID: 15144995 [TBL] [Abstract][Full Text] [Related]
7. Improved mechanical reliability of the HeartMate XVE left ventricular assist system. Pagani FD; Long JW; Dembitsky WP; Joyce LD; Miller LW Ann Thorac Surg; 2006 Oct; 82(4):1413-8. PubMed ID: 16996944 [TBL] [Abstract][Full Text] [Related]
8. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients. Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262 [TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes are similar in pulsatile and nonpulsatile left ventricular assist device recipients. Feller ED; Sorensen EN; Haddad M; Pierson RN; Johnson FL; Brown JM; Griffith BP Ann Thorac Surg; 2007 Mar; 83(3):1082-8. PubMed ID: 17307463 [TBL] [Abstract][Full Text] [Related]
10. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device. John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822 [TBL] [Abstract][Full Text] [Related]
11. Effects of pulsatile- and continuous-flow left ventricular assist devices on left ventricular unloading. Garcia S; Kandar F; Boyle A; Colvin-Adams M; Lliao K; Joyce L; John R J Heart Lung Transplant; 2008 Mar; 27(3):261-7. PubMed ID: 18342746 [TBL] [Abstract][Full Text] [Related]
12. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices. Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570 [TBL] [Abstract][Full Text] [Related]
20. Acquired von Willebrand syndrome after exchange of the HeartMate XVE to the HeartMate II ventricular assist device. Malehsa D; Meyer AL; Bara C; StrĂ¼ber M Eur J Cardiothorac Surg; 2009 Jun; 35(6):1091-3. PubMed ID: 19303790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]